Cantargia appoints Monic Stuart as chief medical officer

PUBT · 1d ago
Cantargia appoints Monic Stuart as chief medical officer
  • Cantargia appointed Monic Stuart chief medical officer, effective immediately.
  • Stuart will lead nadunolimab’s clinical development across blood cancers and solid tumors.
  • She brings more than 20 years of oncology drug development experience, including senior leadership roles at Genentech and Geron.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cantargia AB published the original content used to generate this news brief on October 26, 2026, and is solely responsible for the information contained therein.